How Gossamer Bio Structured a $250 Million Bet on Its Only DrugBusiness PenAugust 21, 2026 August 21, 2026 [stock_market_widget type=”card” template=”basic2″ assets=”GOSS” realtime=”true” api=”yahoo-finance”] When a small drug developer runs low on cash, it faces an uncomfortable choice: raise money on tough terms...